Profile
Sector:
Consumer DefensiveIndustry:
Household & Personal ProductsCountry:
United StatesIPO:
13 September 2019Website:
http://www.forhims.comNext earnings report:
07 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:59:43 GMTDividend
Analysts recommendations
Institutional Ownership
HIMS Latest News
Hims & Hers Health is a high growth, healthcare startup stepping into the GLP-1 space.
A short report was published that makes a case against Hims & Hers' new GLP-1 product. The report was put out by a media organization with ties to a fund that is also a short-seller of the stock.
Hims & Hers Health (NYSE: HIMS ) stock is taking a tumble after Hunterbrook Media released a short report on the telehealth company. Hunterbrook operates an interesting business model, as it publishes research on stocks through Hunterbrook Media while sometimes taking a position in the same stock through its hedge fund affiliate, Hunterbrook Capital.
Summer has officially begun, but some stocks are receiving a chilly reception today.
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers has entered the popular GLP-1 agonist category. Weight loss has quickly become a significant, potentially unexpected catalyst.
GLP-1s could be the product that pushes Hims & Hers over the edge to mainstream adoption.
Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
Shares of Hims & Hers Health (NYSE: HIMS ) stock are skyrocketing higher by over 25% after the telehealth company announced that it would provide access to GLP-1 weight-loss injections. Hims & Hers has partnered with an undisclosed manufacturer of generic and 503B compounded injectable medications to provide the injections.
What type of business is Hims & Hers Health?
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
What sector is Hims & Hers Health in?
Hims & Hers Health is in the Consumer Defensive sector
What industry is Hims & Hers Health in?
Hims & Hers Health is in the Household & Personal Products industry
What country is Hims & Hers Health from?
Hims & Hers Health is headquartered in United States
When did Hims & Hers Health go public?
Hims & Hers Health initial public offering (IPO) was on 13 September 2019
What is Hims & Hers Health website?
https://www.forhims.com
Is Hims & Hers Health in the S&P 500?
No, Hims & Hers Health is not included in the S&P 500 index
Is Hims & Hers Health in the NASDAQ 100?
No, Hims & Hers Health is not included in the NASDAQ 100 index
Is Hims & Hers Health in the Dow Jones?
No, Hims & Hers Health is not included in the Dow Jones index
When does Hims & Hers Health report earnings?
The next expected earnings date for Hims & Hers Health is 07 August 2024